Ann-Kathrin Eisfeld Molecular, Cellular and Developmental Biology

$ 19.00

4.8 (361) In stock

Molecular, Cellular and Developmental Biology Program

A Weibull Mixture Cure Frailty Model for High-dimensional Covariates

Highlight, take notes, and search in the book

Applied Cell and Molecular Biology for Engineers

Immunosuppression and outcomes in adult patients with de novo acute myeloid leukemia with normal karyotypes

Dr. Ann-Kathrin Eisfeld, MD – Columbus, OH

Frontiers in Cell and Developmental Biology

Frontiers Integrative Analysis of Novel Metabolic Subtypes in Pancreatic Cancer Fosters New Prognostic Biomarkers

A single inactivating amino acid change in the SARS-CoV-2 NSP3 Mac1 domain attenuates viral replication in vivo

The 14q32.31 DLK1-DIO3 MIR300 tumor suppressor promotes leukemogenesis by inducing cancer stem cell quiescence and inhibiting NK cell anti-cancer immunity

The Eisfeld Lab OSUCCC – James

Evolutionary Cell Biology

Developmental Biology - from Stem Cells to Morphogenesis - 14th edition

Prognostic impact of the AML ELN2022 risk classification in patients undergoing allogeneic stem cell transplantation

Discovery of LYC-55716: A Potent, Selective, and Orally Bioavailable Retinoic Acid Receptor-Related Orphan Receptor-γ (RORγ) Agonist for Use in Treating Cancer

Dr Eisfeld on Timing of Molecular Testing and the Start of Treatment in AML

Expert Profile: Erin Hertlein